BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Acetaminophen
,
rs7903146
,
DRD2
,
Response to oxidative stress
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
B-cell lymphoma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
LYZ
BCL2
CXCR4
FOSB
JUN
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
heterocycle metabolic process
heterocyclic compound binding
PUJANA_BRCA1_PCC_NETWORK
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
BRD-2-mediated lymphomas
Myeloma versus other lymphoma cell lines
Mouse plasmacytoma gene expression profiling
HLA-B27 modulation of inflammatory response to LPS in U937 cells
PBMCs from B-cell chronic lymphocytic leukemia with or without mutant Ig heavy chain
Explore Curated Studies Results
Literature
Most Relevant Literature
Evolving molecular classification of aggressive B-cell lymphoma.
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Tar…
Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
Cancer Biomarkers V: Update on B-Cell Lymphoma Biomarkers.
Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multi-CAR-T Cells Targeting B Cell Lymphomas
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell …
Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma
Omic Technologies Applied to the Study of Diffuse Large B-cell Lymphoma and High-grade B-cell Lympho…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ